What is Glucuronidation
Glucuronidation is a major Phase II metabolic pathway where UDP-glucuronosyltransferase (UGT) enzymes conjugate glucuronic acid to drugs and endogenous compounds, converting them into hydrophilic, negatively charged glucuronides that are more easily eliminated from the body 1.
Mechanism and Location
Glucuronidation occurs primarily in the liver, though UGT enzymes are also present in the gastrointestinal tract, kidneys, brain, and other organs 2. The process involves:
- UGT enzymes catalyzing the transfer of glucuronic acid from UDP-glucuronic acid (the cosubstrate) to the parent compound 1
- The active site of UGTs faces the luminal space of the endoplasmic reticulum, creating diffusional barriers for substrates and products 3
- The resulting glucuronides are hydrophilic and negatively charged, requiring efflux transporters to exit cells 1
Clinical Significance
Glucuronidation serves as a critical detoxification mechanism but can also be a barrier to oral drug bioavailability 4. Key clinical implications include:
Impact on Drug Disposition
- First-pass metabolism via glucuronidation often results in poor oral bioavailability and reduced drug efficacy 4
- The elimination of parent compounds via glucuronidation is controlled by two forces: UGT enzyme activity and efflux transporter function 1
- Contrary to common assumptions, hepatocytes can efficiently clear gut-generated glucuronides through biliary excretion, not just urinary elimination 1
Factors Affecting Glucuronidation
Multiple factors influence glucuronidation capacity 5:
- Age (especially neonatal period with reduced activity)
- Cigarette smoking
- Diet
- Disease states
- Coadministered drugs
- Ethnicity and genetics
- Hormonal effects
Drug-Drug Interactions
UGT-mediated drug interactions are generally less than 2-fold in magnitude (compared to CYP interactions) because of relatively high UGT Km values and substrate overlap among multiple isozymes 3. However, UGT genetic deficiency, polymorphisms, or inhibition can lead to inherited disorders or drug-induced toxicities 4.
Recycling and Prolonged Exposure
Biliary- and enteric-eliminated glucuronides participate in recycling schemes involving intestinal microbes, which prolong both local and systemic exposure, albeit at low concentrations 1. This recycling impacts the apparent plasma half-life of parent compounds and extends gut and colon exposure 1.
Regulation
Glucuronidation is under dual control 6:
- Specific isozyme expression levels - modulated by chemical inducers and hormones
- Functional state modulation - influenced by the endoplasmic reticulum membrane environment and UDP-glucuronic acid transport across the membrane
Recent evidence indicates that the same nuclear receptors regulating CYP enzymes (CAR, AH receptor, PXR) also mediate regulation of specific UGT isoforms 3.